Sanity Group Secures $17 Million in Funding to Fuel Expansion Across Europe

Sanity Group, a prominent Berlin-based cannabis company focused on the medicinal and health applications of cannabinoids, has successfully raised 17 million dollars in funding. The company's multifaceted operations range from medicinal cannabis to consumer health and technology. With a strong commitment to ensuring that all individuals have access to a healthy lifestyle, Sanity Group develops and delivers cutting-edge, cannabinoid-based pharmaceuticals and wellness products to patients and consumers across Europe. This recent funding will fuel the company's mission to expand its reach and offerings, aiming to partner with cultivation facilities worldwide looking to enhance their presence in the European market. For more information about our company and career opportunities, please visit our website.